Hilton Suzhou New District-Tourism news

Tourism News

Transcelestial unveils CENTAURI+ - World's First Bandwidth-On-Demand, Quantum-Safe, Telco-Grade Laser Terminal2026-03-03
SAN FRANCISCO, March 3, 2026 /PRNewswire/ -- Transcelestial today announces CENTAURI+, world's first bandwidth-on-demand wireless laser communications platform, designed to upgrade the commercially successful CENTAURI laser communications terminal into an intelligently manageable and quantum-secure product, suitable for the shifting AI-workloads in toda...
Transcelestial unveils CENTAURI+ - World's First Bandwidth-On-Demand, Quantum-Safe, Telco-Grade Laser Terminal2026-03-03
SAN FRANCISCO, March 3, 2026 /PRNewswire/ -- Transcelestial today announces CENTAURI+, world's first bandwidth-on-demand wireless laser communications platform, designed to upgrade the commercially successful CENTAURI laser communications terminal into an intelligently manageable and quantum-secure product, suitable for the shifting AI-workloads in toda...
Huawei Collaborates with GCC to Launch the AIDC Ecosystem Co-construction Initiative2026-03-03
BARCELONA, Spain, March 3, 2026 /PRNewswire/ -- At the Global Digital Power Forum during MWC Barcelona 2026, Huawei Digital Power launched the AIDC Ecosystem Co-construction Initiative with Global Computing Consortium (GCC) and unveiled the New-Gen AI-Powered Green Site to empower the ICT industry in the AI era. As the intelligent era is advancing rapidly, ...
Huawei Collaborates with GCC to Launch the AIDC Ecosystem Co-construction Initiative2026-03-03
BARCELONA, Spain, March 3, 2026 /PRNewswire/ -- At the Global Digital Power Forum during MWC Barcelona 2026, Huawei Digital Power launched the AIDC Ecosystem Co-construction Initiative with Global Computing Consortium (GCC) and unveiled the New-Gen AI-Powered Green Site to empower the ICT industry in the AI era. As the intelligent era is advancing rapidly, ...
Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China2026-03-03
First glucokinase-activator (GKA) approval outside mainland China Approval supports a differentiated approach to Type 2 diabetes (T2D) management Hong Kong will serve as Hua Medicine's launchpad for international market expansion SHANGHAI and HONG KONG, March 3, 2026 /PRNewswire/ -- Hua Medicine ("the Company", Hong Kong S...
Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China2026-03-03
First glucokinase-activator (GKA) approval outside mainland China Approval supports a differentiated approach to Type 2 diabetes (T2D) management Hong Kong will serve as Hua Medicine's launchpad for international market expansion SHANGHAI and HONG KONG, March 3, 2026 /PRNewswire/ -- Hua Medicine ("the Company", Hong Kong S...
Huawei Launches New-Gen AI-Powered Green Site and GW-Level AIDC Solutions to Empower Operators2026-03-03
BARCELONA, Spain, March 3, 2026 /PRNewswire/ -- At the Product & Solution Launch event during MWC Barcelona 2026, Bob He, Vice President of Huawei Digital Power, unveiled the New-Generation AI-Powered Green Site and GW-level AIDC Solutions. These solutions help operators build zero-carbon target networks and lay a solid foundation for AI computing in the...
Huawei Launches New-Gen AI-Powered Green Site and GW-Level AIDC Solutions to Empower Operators2026-03-03
BARCELONA, Spain, March 3, 2026 /PRNewswire/ -- At the Product & Solution Launch event during MWC Barcelona 2026, Bob He, Vice President of Huawei Digital Power, unveiled the New-Generation AI-Powered Green Site and GW-level AIDC Solutions. These solutions help operators build zero-carbon target networks and lay a solid foundation for AI computing in the...
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform2026-03-03
NEW YORK, March 3, 2026 /PRNewswire/ -- Royalty Pharma plc (Nasdaq: RPRX) announced the appointment of Kenneth Sun as Senior Vice President and Head of Asia, effective May 2026. Ken will be based in Hong Kong and lead the company's royalty business in Asia. Ken joins Royalty Pharma from Morgan Stanley, where he was Head of Asia Pacific Healthcare Invest...
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform2026-03-03
NEW YORK, March 3, 2026 /PRNewswire/ -- Royalty Pharma plc (Nasdaq: RPRX) announced the appointment of Kenneth Sun as Senior Vice President and Head of Asia, effective May 2026. Ken will be based in Hong Kong and lead the company's royalty business in Asia. Ken joins Royalty Pharma from Morgan Stanley, where he was Head of Asia Pacific Healthcare Invest...

Hilton Suzhou New District

Tourism News

Transcelestial unveils CENTAURI+ - World's First Bandwidth-On-Demand, Quantum-Safe, Telco-Grade Laser Terminal2026-03-03

Transcelestial unveils CENTAURI+ - World's First Bandwidth-On-Demand, Quantum-Safe, Telco-Grade Laser Terminal2026-03-03

Huawei Collaborates with GCC to Launch the AIDC Ecosystem Co-construction Initiative2026-03-03

Huawei Collaborates with GCC to Launch the AIDC Ecosystem Co-construction Initiative2026-03-03

Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China2026-03-03

Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China2026-03-03

Huawei Launches New-Gen AI-Powered Green Site and GW-Level AIDC Solutions to Empower Operators2026-03-03

Huawei Launches New-Gen AI-Powered Green Site and GW-Level AIDC Solutions to Empower Operators2026-03-03

Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform2026-03-03

Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform2026-03-03

Hilton Suzhou New District